Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Unprecedented eye drop recalls have led to significant health risks, including four fatalities. Learn more to ensure that you guide your patients towards safer, FDA-approved alternatives.
Ophthalmology September 26th 2023
Journal of the American Dental Assocation (JADA)
Discover how new guidelines from the American Academy of Oral and Maxillofacial Radiology are set to change long-standing practices in radiation shielding during dentomaxillofacial imaging. Learn more about what this means for your practice and patient safety.
Dentistry September 18th 2023
Medical Professionals Reference (MPR)
Marlex Pharmaceuticals has initiated a critical recall of specific lots of Digoxin Tablets due to a labeling error. Physicians are urged to exercise extreme caution and verify their inventory to prevent adverse patient outcomes.
Cardiology September 13th 2023
Annals of Internal Medicine
This retrospective cohort study provides evidence that the risk profiles for in-hospital adverse events are similar among haloperidol and atypical antipsychotics in older patients with postoperative delirium.
Hospitalist September 12th 2023
Cancer Therapy Advisor
Explore the contrasting mask policies in US healthcare systems and their implications on patient safety, especially among those most vulnerable to COVID-19.
Hematology/Oncology September 5th 2023
The study reveals that generic Wixela Inhub is comparable to Advair Diskus in both effectiveness and safety for treating COPD. Consider this cost-effective alternative in your treatment plans.
Clinical Pharmacology August 31st 2023